Review Article | Published:

Class 2 CRISPR–Cas RNA-guided endonucleases: Swiss Army knives of genome editing

Nature Structural & Molecular Biology volume 24, pages 882892 (2017) | Download Citation

Abstract

CRISPR–Cas is a bacterial defense system against phage infection and nucleic acid invasion. Class 2 type II CRISPR–Cas9 has also been widely used for genome engineering. Here, we review novel insights into the CRISPR class 2 type V enzymes, specifically Cpf1 and C2c1, which display different DNA-recognition and cleavage characteristics than those of Cas9, the best-characterized member of class 2. Recent structures of these ribonucleoprotein complexes that capture several stages of the endonuclease reaction have provided molecular details of recognition, unzipping and cleavage of the target DNA, allowing their comparison with Cas9. A detailed understanding of these mechanisms is crucial for improving these genome engineering tools and expanding the genomic space that can be targeted.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Accessions

References

  1. 1.

    , , , & Nucleotide sequence of the iap gene, responsible for alkaline phosphatase isozyme conversion in Escherichia coli, and identification of the gene product. J. Bacteriol. 169, 5429–5433 (1987). First report of CRISPR array in bacteria.

  2. 2.

    , & Transcription at different salinities of Haloferax mediterranei sequences adjacent to partially modified PstI sites. Mol. Microbiol. 9, 613–621 (1993).

  3. 3.

    et al. Insertion element IS987 from Mycobacterium bovis BCG is located in a hot-spot integration region for insertion elements in Mycobacterium tuberculosis complex strains. Infect. Immun. 59, 2695–2705 (1991).

  4. 4.

    , , & Identification of genes that are associated with DNA repeats in prokaryotes. Mol. Microbiol. 43, 1565–1575 (2002).

  5. 5.

    , , & A putative viral defence mechanism in archaeal cells. Archaea 2, 59–72 (2006).

  6. 6.

    et al. CRISPR provides acquired resistance against viruses in prokaryotes. Science 315, 1709–1712 (2007).

  7. 7.

    et al. Small CRISPR RNAs guide antiviral defense in prokaryotes. Science 321, 960–964 (2008).

  8. 8.

    , , & Intervening sequences of regularly spaced prokaryotic repeats derive from foreign genetic elements. J. Mol. Evol. 60, 174–182 (2005).

  9. 9.

    et al. C2c1-sgRNA complex structure reveals RNA-guided DNA cleavage mechanism. Mol. Cell 65, 310–322 (2017). Crystal structure of AacC21 in complex with sgRNA and first biochemical analysis of single-nucleotide mismatches between guide RNA and DNA target.

  10. 10.

    , , & PAM-dependent target DNA recognition and cleavage by C2c1 CRISPR-Cas endonuclease. Cell 167, 1814–1828.e12 (2016). Crystal structures of the AacC2c1 ternary complex reveal the catalytic mechanism of double-strand-break formation in C2c1.

  11. 11.

    et al. The crystal structure of Cpf1 in complex with CRISPR RNA. Nature 532, 522–526 (2016). First structure of Cpf1 in complex with crRNA and EM projections of the apo form of Cpf1.

  12. 12.

    , , , & Type V CRISPR-Cas Cpf1 endonuclease employs a unique mechanism for crRNA-mediated target DNA recognition. Cell Res. 26, 901–913 (2016).

  13. 13.

    , & Structure of the Cpf1 endonuclease R-loop complex after target DNA cleavage. Nature 10.1038/nature22398 (2017). First structure of the R loop of Cpf1 after cleavage revealing the different paths taken by the two DNA strands toward the catalytic center.

  14. 14.

    , & Structural basis for guide RNA processing and seed-dependent DNA targeting by CRISPR-Cas12a. Mol. Cell 66, 221–233.e4 (2017). Structure of Cpf1 bound to the crRNA and artificial R loop, mimicking the pre-cleavage state.

  15. 15.

    et al. Crystal structure of Cpf1 in complex with guide RNA and target DNA. Cell 165, 949–962 (2016).First structure of Cpf1 in complex with a DNA target containing the PAM sequence.

  16. 16.

    & CRISPR-Cas9 structures and mechanisms. Annu. Rev. Biophys. 46, 505–529 (2017).

  17. 17.

    & Structures and mechanisms of CRISPR RNA-guided effector nucleases. Curr. Opin. Struct. Biol. 43, 68–78 (2017).

  18. 18.

    , , & Conformational regulation of CRISPR-associated nucleases. Curr. Opin. Microbiol. 37, 110–119 (2017).

  19. 19.

    et al. An updated evolutionary classification of CRISPR-Cas systems. Nat. Rev. Microbiol. 13, 722–736 (2015).

  20. 20.

    et al. Evolution and classification of the CRISPR-Cas systems. Nat. Rev. Microbiol. 9, 467–477 (2011).

  21. 21.

    et al. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337, 816–821 (2012).

  22. 22.

    , , & Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria. Proc. Natl. Acad. Sci. USA 109, E2579–E2586 (2012).

  23. 23.

    et al. Multiplex genome engineering using CRISPR/Cas systems. Science 339, 819–823 (2013).

  24. 24.

    et al. RNA-programmed genome editing in human cells. eLife 2, e00471 (2013).

  25. 25.

    et al. CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering. Nat. Biotechnol. 31, 833–838 (2013).

  26. 26.

    et al. Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system. Cell 163, 759–771 (2015). Characterization of Cpf1 and its use in human cell target editing.

  27. 27.

    et al. Genome-wide specificities of CRISPR-Cas Cpf1 nucleases in human cells. Nat. Biotechnol. 34, 869–874 (2016).

  28. 28.

    et al. Genome-wide analysis reveals specificities of Cpf1 endonucleases in human cells. Nat. Biotechnol. 34, 863–868 (2016).

  29. 29.

    et al. Discovery and functional characterization of diverse class 2 CRISPR-Cas systems. Mol. Cell 60, 385–397 (2015). Identification and characterization of C2c1.

  30. 30.

    A. et al. Cas13b is a type VI-B CRISPR-associated RNA-guided RNase differentially regulated by accessory proteins Csx27 and Csx28. Mol. Cell 65, 618–630.e7 (2017).

  31. 31.

    et al. Nucleic acid detection with CRISPR-Cas13a/C2c2. Science 356, 438–442 (2017).

  32. 32.

    & Exploiting CRISPR-Cas immune systems for genome editing in bacteria. Curr. Opin. Biotechnol. 37, 61–68 (2016).

  33. 33.

    , & Development and applications of CRISPR-Cas9 for genome engineering. Cell 157, 1262–1278 (2014).

  34. 34.

    Genome engineering with targetable nucleases. Annu. Rev. Biochem. 83, 409–439 (2014).

  35. 35.

    Genome editing: progress and challenges for medical applications. Genome Med. 8, 120 (2016).

  36. 36.

    et al. C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector. Science 353, aaf5573 (2016).

  37. 37.

    , , , & Comprehensive analysis of the HEPN superfamily: identification of novel roles in intra-genomic conflicts, defense, pathogenesis and RNA processing. Biol. Direct 8, 15 (2013).

  38. 38.

    et al. Diversity and evolution of class 2 CRISPR-Cas systems. Nat. Rev. Microbiol. 15, 169–182 (2017).

  39. 39.

    et al. Two distinct RNase activities of CRISPR-C2c2 enable guide-RNA processing and RNA detection. Nature 538, 270–273 (2016).

  40. 40.

    et al. The molecular architecture for RNA-guided RNA cleavage by Cas13a. Cell 170, 714–726.e10 (2017).

  41. 41.

    et al. Two distant catalytic sites are responsible for C2c2 RNase activities. Cell 168, 121–134.e12 (2017).

  42. 42.

    et al. Guide-bound structures of an RNA-targeting A-cleaving CRISPR–Cas13a enzyme. Nat. Struct. Mol. Biol. (2017).

  43. 43.

    , , , & The CRISPR-associated DNA-cleaving enzyme Cpf1 also processes precursor CRISPR RNA. Nature 532, 517–521 (2016). Identification and characterization of the RNase activity in Cpf1 showing that it is able to process pre-crRNA into mature crRNA.

  44. 44.

    et al. A CRISPR-Cpf1 system for efficient genome editing and transcriptional repression in plants. Nat. Plants 3, 17103 (2017).

  45. 45.

    et al. Efficient transcriptional gene repression by Type V-A CRISPR-Cpf1 from Eubacterium eligens. ACS Synth. Biol. 6, 1273–1282 (2017).

  46. 46.

    et al. Engineered Cpf1 variants with altered PAM specificities. Nat. Biotechnol. 35, 789–792 (2017).

  47. 47.

    , & CRISPR-Cpf1: a new tool for plant genome editing. Trends Plant Sci. 22, 550–553 (2017).

  48. 48.

    et al. CRISPR-Cpf1 assisted genome editing of Corynebacterium glutamicum. Nat. Commun. 8, 15179 (2017).

  49. 49.

    et al. Targeted mutagenesis in mice by electroporation of Cpf1 ribonucleoproteins. Nat. Biotechnol. 34, 807–808 (2016).

  50. 50.

    , , , & Multiplex gene editing in rice using the CRISPR-Cpf1 system. Mol. Plant 10, 1011–1013 (2017).

  51. 51.

    et al. Multiplex gene editing by CRISPR-Cpf1 using a single crRNA array. Nat. Biotechnol. 35, 31–34 (2017).

  52. 52.

    et al. CRISPR-Cpf1 correction of muscular dystrophy mutations in human cardiomyocytes and mice. Sci. Adv. 3, e1602814 (2017).

  53. 53.

    et al. Structures of Cas9 endonucleases reveal RNA-mediated conformational activation. Science 343, 1247997 (2014).

  54. 54.

    , , , & STRUCTURAL BIOLOGY. A Cas9-guide RNA complex preorganized for target DNA recognition. Science 348, 1477–1481 (2015). Crystal structure of Cas9 binary complex.

  55. 55.

    et al. Structures of a CRISPR-Cas9 R-loop complex primed for DNA cleavage. Science 351, 867–871 (2016). Crystal structure of the Cas9 R loop before cleavage and cryo-EM structure of Cas9 in complex with a long DNA target revealing the position of the catalytic domains RuvC and HNH and the enter and exit point of the DNA in Cas9.

  56. 56.

    , & Planting the seed: target recognition of short guide RNAs. Trends Microbiol. 22, 74–83 (2014).

  57. 57.

    , , , & DNA interrogation by the CRISPR RNA-guided endonuclease Cas9. Nature 507, 62–67 (2014).

  58. 58.

    et al. Structural basis for the altered PAM recognition by engineered CRISPR-Cpf1. Mol. Cell 67, 139–147 e2 (2017).

  59. 59.

    , , & Structural basis of PAM-dependent target DNA recognition by the Cas9 endonuclease. Nature 513, 569–573 (2014).

  60. 60.

    , & The shape of the DNA minor groove directs binding by the DNA-bending protein Fis. Genes Dev. 24, 814–826 (2010).

  61. 61.

    et al. The role of DNA shape in protein-DNA recognition. Nature 461, 1248–1253 (2009).

  62. 62.

    et al. RNA-guided complex from a bacterial immune system enhances target recognition through seed sequence interactions. Proc. Natl. Acad. Sci. USA 108, 10092–10097 (2011).

  63. 63.

    et al. Interference by clustered regularly interspaced short palindromic repeat (CRISPR) RNA is governed by a seed sequence. Proc. Natl. Acad. Sci. USA 108, 10098–10103 (2011).

  64. 64.

    et al. High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity. Nat. Biotechnol. 31, 839–843 (2013).

  65. 65.

    & Defining and improving the genome-wide specificities of CRISPR-Cas9 nucleases. Nat. Rev. Genet. 17, 300–312 (2016).

  66. 66.

    et al. CIRCLE-seq: a highly sensitive in vitro screen for genome-wide CRISPR-Cas9 nuclease off-targets. Nat. Methods 14, 607–614 (2017).

  67. 67.

    & The genome editing revolution: a CRISPR-Cas TALE off-target story. BioEssays 38 (Suppl 1), S4–S13 (2016).

  68. 68.

    , & Hybridization of RNA to double-stranded DNA: formation of R-loops. Proc. Natl. Acad. Sci. USA 73, 2294–2298 (1976).

  69. 69.

    et al. Crystal structure of Cas9 in complex with guide RNA and target DNA. Cell 156, 935–949 (2014).

  70. 70.

    , & Assembly of Francisella novicida Cpf1 endonuclease in complex with guide RNA and target DNA. Acta Crystallogr. F Struct. Biol. Commun. 73, 409–415 (2017).

  71. 71.

    , , & Conformational control of DNA target cleavage by CRISPR-Cas9. Nature 527, 110–113 (2015).

  72. 72.

    , , , & CRISPR-Cas9 conformational activation as elucidated from enhanced molecular simulations. Proc. Natl. Acad. Sci. USA 114, 7260–7265 (2017).

  73. 73.

    et al. Visualizing phosphodiester-bond hydrolysis by an endonuclease. Nat. Struct. Mol. Biol. 22, 65–72 (2015).

  74. 74.

    et al. Broadening the targeting range of Staphylococcus aureus CRISPR-Cas9 by modifying PAM recognition. Nat. Biotechnol. 33, 1293–1298 (2015).

  75. 75.

    et al. Engineered CRISPR-Cas9 nucleases with altered PAM specificities. Nature 523, 481–485 (2015).

  76. 76.

    , & CRISPR-based technologies for the manipulation of eukaryotic genomes. Cell 168, 20–36 (2017).

  77. 77.

    et al. Rationally engineered Cas9 nucleases with improved specificity. Science 351, 84–88 (2016).

  78. 78.

    & CRISPR-Cas adaptation: insights into the mechanism of action. Nat. Rev. Microbiol. 14, 67–76 (2016).

  79. 79.

    , & Biology and applications of CRISPR systems: harnessing nature's toolbox for genome engineering. Cell 164, 29–44 (2016).

  80. 80.

    , , & Unravelling the structural and mechanistic basis of CRISPR-Cas systems. Nat. Rev. Microbiol. 12, 479–492 (2014).

  81. 81.

    , & Proteins and DNA elements essential for the CRISPR adaptation process in Escherichia coli. Nucleic Acids Res. 40, 5569–5576 (2012).

  82. 82.

    et al. Cas1-Cas2 complex formation mediates spacer acquisition during CRISPR-Cas adaptive immunity. Nat. Struct. Mol. Biol. 21, 528–534 (2014).

  83. 83.

    , , , & Foreign DNA capture during CRISPR-Cas adaptive immunity. Nature 527, 535–538 (2015).First crystal structure of Cas1–Cas2 in complex with a DNA protospacer.

  84. 84.

    et al. CRISPR-Cas: adapting to change. Science 356, eaal5056 (2017).

  85. 85.

    , , & Short motif sequences determine the targets of the prokaryotic CRISPR defence system. Microbiology 155, 733–740 (2009).

  86. 86.

    , , & Biogenesis pathways of RNA guides in archaeal and bacterial CRISPR-Cas adaptive immunity. FEMS Microbiol. Rev. 39, 428–441 (2015).

  87. 87.

    et al. CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III. Nature 471, 602–607 (2011).

  88. 88.

    et al. Characterization of CRISPR RNA processing in Clostridium thermocellum and Methanococcus maripaludis. Nucleic Acids Res. 40, 9887–9896 (2012).

  89. 89.

    et al. Structural basis for the canonical and non-canonical PAM recognition by CRISPR-Cpf1. Mol. Cell 67, 633–645.e3 (2017).

  90. 90.

    et al. Processing-independent CRISPR RNAs limit natural transformation in Neisseria meningitidis. Mol. Cell 50, 488–503 (2013).

  91. 91.

    , , , & RNA-guided editing of bacterial genomes using CRISPR-Cas systems. Nat. Biotechnol. 31, 233–239 (2013).

Download references

Acknowledgements

The Novo Nordisk Foundation Center for Protein Research is financially supported by the Novo Nordisk Foundation (Grant NNF14CC0001). This work was also supported by a grant from the Danish Cancer Society to G.M. We thank the Swiss Light Source (PSI, Switzerland) and the Computerome, the Danish National Computer for Life Sciences, for supporting our research.

Author information

Author notes

    • Stefano Stella
    •  & Pablo Alcón

    These authors contributed equally to this work.

Affiliations

  1. Protein Structure & Function Programme, Structural Molecular Biology Group, Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

    • Stefano Stella
    • , Pablo Alcón
    •  & Guillermo Montoya

Authors

  1. Search for Stefano Stella in:

  2. Search for Pablo Alcón in:

  3. Search for Guillermo Montoya in:

Competing interests

The authors declare no competing financial interests.

Corresponding authors

Correspondence to Stefano Stella or Guillermo Montoya.

About this article

Publication history

Received

Accepted

Published

DOI

https://doi.org/10.1038/nsmb.3486

Further reading